Enhancing the Therapeutic Potential of Sulfamidase for the Treatment of Mucopolysaccharidosis IIIA

Mucopolysaccharidosis type IIIA (MPS-IIIA) is a lysosomal storage disorder (LSD) caused by inherited defect of sulfamidase, a lysosomal sulfatase. MPS-IIIA is one of the most common and severe forms of LSDs with CNS involvement. Presently there is no cure. Here we have developed a new gene delivery...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorrentino, Nicolina Cristina, Cacace, Vincenzo, De Risi, Maria, Maffia, Veronica, Strollo, Sandra, Tedesco, Novella, Nusco, Edoardo, Romagnoli, Noemi, Ventrella, Domenico, Huang, Yan, Liu, Nan, Kalled, Susan L., Choi, Vivian W., De Leonibus, Elvira, Fraldi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881609/
https://www.ncbi.nlm.nih.gov/pubmed/31788497
http://dx.doi.org/10.1016/j.omtm.2019.10.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881609/
https://www.ncbi.nlm.nih.gov/pubmed/31788497
http://dx.doi.org/10.1016/j.omtm.2019.10.009

Ejemplares similares